Incidence and Management of Splanchnic Vein Thrombosis in Pancreatic Diseases

Borbély, Ruben Zsolt* [Borbély, Ruben Zsolt (Radiológia), author] Bajcsy-Zsilinszky Kórház; Centre for Translational Medicine (SU / KSZE); Teutsch, Brigitta* [Teutsch, Brigitta (Gasztroenterológia), author] Radiológia Tanszék (SU / FM / C / OKK); Institute for Translational Medicine (UP / UPMS); Centre for Translational Medicine (SU / KSZE); Hegyi, Péter ✉ [Hegyi, Péter (Gasztroenterológia), author] Institute of Pancreatic Diseases (SU / FM / C); Centre for Translational Medicine (SU / KSZE); Institute for Translational Medicine (UP / UPMS)

English Survey paper (Journal Article) Scientific
  • SJR Scopus - Gastroenterology: D1
Identifiers
Fundings:
  • (EKÖP-2024-239)
Subjects:
  • General and internal medicine
Splanchnic vein thrombosis (SVT) in pancreatic disease has a 20%–30% incidence rate, leading to increased mortality and complication rates. Therefore, the aim of this review is to summarize recent evidence about the incidence, risk factors, and management of pancreatic cancer, pancreatic cystic neoplasm‐, and pancreatitis‐related SVT. Doppler ultrasound should be the first imaging choice, followed by contrast‐enhanced computed tomography or magnetic resonance imaging. Data regarding SVT treatment in acute pancreatitis and pancreatic cancer are scarce; however, for venous thromboembolism treatment, direct oral anticoagulants and low molecular weight heparin have been effective. Further trials must investigate the length of anticoagulant treatment and the need for interventional radiological procedures.
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-01 22:24